LifeView™ PGT was created by Genomic Prediction, based on rigorous peer-reviewed validation, and more data-per-embryo than any other preimplantation genetic test available today.
LifeView PGT is proven to provide:
- Improved accuracy
- More available embryos for transfer
- Lower miscarriage rates
- Higher pregnancy rates
Your LifeView Team
LifeView is led by the world’s leading experts in their respective fields. When you choose to work with us you can expect to have a dedicated team member walk you through the testing process and to support you each step of the way.
Dr. Nathan Treff, PHD, HCLD
Co-founder, Chief Science Officer, and Clinical Laboratory Director
Nathan is an admired, multi-award winning reproductive scientist, inventor, published researcher with a long history in reproductive genetic testing. He’s an Associate Professor at Rutgers School of Medicine and has published over 120 peer reviewed papers.
Kelly Ketterson
Chief Executive Officer
Kelly is an award winning leader who has been successfully directing companies in the IVF industry and expanding education of the field for several decades. Although she’s decorated with accolades and notoriety she is most defined by her humanity and empathy. Kelly’s commitment to this work is personal as her son was a result of fertility treatments.
Jennifer Eccles, LCGC
Senior Director and Head of Clinical Genetics
Jennifer is an expert with 20+ years in reproductive clinical genetics. As a genetic counselor her advocacy and publication history is focused on the patient’s perspective of genetics and clinical testing.
Diego Marin, PhD
Assistant Laboratory Director and Head of LATAM Business Development
Diego is a reproductive geneticist with an embryology background. Born in Costa Rica he passionately leads our business development in Latin America.
Talia Metzgar, RN
Senior Director and Head of Medical Affairs
Talia has spent her career helping thousands of patients through the IVF process. She’s devoted to ensuring that the patient’s needs come first.